Skip to content
XOMA
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Contact Us
  • Royalty Portfolio
  • Opportunities
    • Overview
    • Royalty Acquisition
    • Assets Available for Licensing
      • Phage Display Platform
      • IL-2 Antibody
      • Anti-prolactin Antibody
      • XMetA Portfolio
      • Anti-PTH1R Antibody
  • News
    • Company & Partner News
    • Press Releases
  • Investors
    • Overview
    • News & Events
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Contact
XOMA
XOMA
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Contact Us
  • Royalty Portfolio
  • Opportunities
    • Overview
    • Royalty Acquisition
    • Assets Available for Licensing
      • Phage Display Platform
      • IL-2 Antibody
      • Anti-prolactin Antibody
      • XMetA Portfolio
      • Anti-PTH1R Antibody
  • News
    • Company & Partner News
    • Press Releases
  • Investors
    • Overview
    • News & Events
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Company & Partner News
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Charts
    • Historical Data
    • IRS Form 8937
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

XOMA Issued Two New U.S. Patents Covering XOMA 052

Nov 09, 2010 8:00am EST

XOMA Reports Third Quarter 2010 Financial Results

Nov 04, 2010 4:01pm EDT

XOMA 3AB Progress Presented at National Biodefense Research Meeting

Nov 02, 2010 8:00am EDT

XOMA Awarded $977,917 in Grants Under the Patient Protection and Affordable Care Program

Nov 01, 2010 3:59pm EDT

XOMA Receives $2.0 Million Payment Under Antibody Discovery Collaboration With Kaketsuken

Nov 01, 2010 8:00am EDT

XOMA to Announce 2010 Third Quarter Financial Results and Host Webcast Conference Call on November 4, 2010

Oct 28, 2010 8:00am EDT

XOMA Announces Presentation and Webcast at NewsMakers in the Biotech Industry Conference

Oct 18, 2010 8:00am EDT

XOMA Announces Presentation and Webcast at BIO Investor Forum

Oct 04, 2010 8:00am EDT

XOMA 052 Phase 2a Trial Enrollment Completed

Sep 29, 2010 8:00am EDT

XOMA Announces Presentation and Webcast at Rodman & Renshaw Annual Global Investment Conference

Sep 08, 2010 4:05pm EDT
RSS
  • Prev
    • 1...
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • ...43
    Next
    • Email Alerts
    • RSS News Feed
    • Terms of Use

    © 2023 XOMA Corporation.  All rights reserved.

    All references to “portfolio” on this website refer strictly to milestone and/or royalty rights associated with a basket of drug products in development. All references to “assets” on this website refer strictly to milestone and/or royalty rights associated with individual drug product candidates in development. References to royalties or royalty rates strictly refer to future potential payment streams regardless of whether or not they are technically defined as royalties in the underlying contractual agreement; further, any rates referenced herein are subject to potential future contractual adjustments.

    • Follow us:
    © 2023 XOMA • Powered by GeneratePress
    Scroll back to top